Research Analysts Set Expectations for PAHC FY2025 Earnings

Phibro Animal Health Co. (NASDAQ:PAHC) – Analysts at Zacks Research lifted their FY2025 EPS estimates for shares of Phibro Animal Health in a report issued on Wednesday, March 12th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $1.91 per share for the year, up from their previous forecast of $1.87. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%.

Several other equities research analysts have also commented on the company. StockNews.com upgraded Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Saturday. Morgan Stanley upped their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Finally, Barclays upped their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research note on Monday, February 10th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $21.00.

Phibro Animal Health Price Performance

Phibro Animal Health stock opened at $21.25 on Monday. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The company’s fifty day moving average price is $22.57 and its 200 day moving average price is $22.59. The stock has a market capitalization of $860.69 million, a P/E ratio of 44.27, a P/E/G ratio of 0.45 and a beta of 0.58. Phibro Animal Health has a 1 year low of $12.05 and a 1 year high of $26.55.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.26%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 100.00%.

Hedge Funds Weigh In On Phibro Animal Health

Several large investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its position in Phibro Animal Health by 1.4% in the fourth quarter. Vanguard Group Inc. now owns 1,514,736 shares of the company’s stock valued at $31,809,000 after purchasing an additional 20,604 shares during the period. American Century Companies Inc. lifted its stake in Phibro Animal Health by 18.0% during the 4th quarter. American Century Companies Inc. now owns 635,599 shares of the company’s stock worth $13,348,000 after acquiring an additional 96,787 shares in the last quarter. Nuveen Asset Management LLC grew its position in Phibro Animal Health by 21.4% in the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company’s stock valued at $12,348,000 after acquiring an additional 103,618 shares in the last quarter. Renaissance Technologies LLC increased its stake in Phibro Animal Health by 1.9% during the fourth quarter. Renaissance Technologies LLC now owns 557,800 shares of the company’s stock worth $11,714,000 after purchasing an additional 10,600 shares during the period. Finally, Geode Capital Management LLC lifted its position in shares of Phibro Animal Health by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 515,979 shares of the company’s stock worth $10,838,000 after purchasing an additional 8,510 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.